| निर्धारित समय - सीमा | अनुमानित कीमत | अतीत | ऐतिहासिक | अंतर्दृष्टि |
|---|---|---|---|---|
| कल | $23.40 ▲ +1.86% | कल | $22.79 ▼ -0.78% | Tomorrow's 10x Genomics Inc. Class A Common Stock (TXG) setup is anchored to $22.97 and targets $23.40 (+1.86%). The near-term read is upside; watch $23.66 / $22.28 because daily realized volatility is about 8.00%. |
Tomorrow's 10x Genomics Inc. Class A Common Stock (TXG) setup is anchored to $22.97 and targets $23.40 (+1.86%). The near-term read is upside; watch $23.66 / $22.28 because daily realized volatility is about 8.00%. | ||||
| सप्ताह | $24.30 ▲ +5.77% | पिछले सप्ताह | $22.41 ▼ -2.43% | The 7-day 10x Genomics Inc. Class A Common Stock model moves from $22.41 to $24.30 (+5.77%). It gives upside momentum context for this stock, so breaks around $23.66 / $22.28 matter more than a single tick. |
The 7-day 10x Genomics Inc. Class A Common Stock model moves from $22.41 to $24.30 (+5.77%). It gives upside momentum context for this stock, so breaks around $23.66 / $22.28 matter more than a single tick. | ||||
| महीना | $25.80 ▲ +12.30% | पिछला महीना | $21.78 ▼ -5.17% | The 1-month 10x Genomics Inc. Class A Common Stock target is $25.80 (+12.30%), compared with the live reference near $22.97. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month 10x Genomics Inc. Class A Common Stock target is $25.80 (+12.30%), compared with the live reference near $22.97. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| वर्ष | $28.04 ▲ +22.08% | पिछले साल | $20.84 ▼ -9.27% | The 1-year 10x Genomics Inc. Class A Common Stock scenario points to $28.04 (+22.08%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year 10x Genomics Inc. Class A Common Stock scenario points to $28.04 (+22.08%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 साल | $33.31 ▲ +45.00% | 5 साल पहले | $18.63 ▼ -18.90% | The 5-year 10x Genomics Inc. Class A Common Stock view is $33.31 (+45.00%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year 10x Genomics Inc. Class A Common Stock view is $33.31 (+45.00%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| सूचक | कीमत | संकेत |
|---|---|---|
| Price | $22.97 | Mid |
| Daily Change | -6.59% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 71% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $22.97 | Daily Change | -6.59% |
| Market Cap | $2.93B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.